The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the pro-B Ba/F3 cell line

被引:49
作者
Baixeras, E [1 ]
Jeay, S [1 ]
Kelly, PA [1 ]
Postel-Vinay, MC [1 ]
机构
[1] Fac Med Necker, INSERM, U344, F-75730 Paris 15, France
关键词
D O I
10.1210/en.142.7.2968
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Biological actions of GH can be direct or mediated through insulinlike growth factor I(IGF-I). In the interleukin-3 (IL-3)-dependent Ba/F3 cell line, IGF-I induces cell cycle entry and proliferation. Ba/F3 cells expressing the rat GH receptor (Ba/F3 GHR cells) have been shown to escape from apoptosis and to proliferate under GH stimulation. Using the Ba/F3 GHR cell model, we sought to dissect the signals elicited specifically by IGF-I or GH. In contrast to IGF-I or IL-3, GH is able to maintain cell cycle entry of Ba/F3 GHR cells cultured for 7 days in the absence of serum. The presence of IGF-I messenger RNA was not detected by RT-PCR, and by RIA, IGF-I was not found in culture medium of Ba/F3 GHR cells, unstimulated or stimulated by GH. Moreover, the addition of an anti-IGF-I antibody that blocks IGF-I effects suggests that the actions of GH are not mediated by IGF-I, but appear to be direct. GH or IGF-I stimulation increased expression of cyclins A and D-1 with comparable kinetics, whereas expression of pal(waf1/cip1) seemed delayed in IGF-I-stimulated cells compared with that in GH-stimulated cells. Contrary to GH or IL-3, IGF-I did not induce nuclear factor-kappaB DNA-binding activity in Ba/F3 cells. Inhibition of nuclear factor-kappaB through expression of the mutant I kappaB alpha (A32/36) abrogated the GH-mediated survival signal, but did not result in alterations of the cell cycle in Ba/F3 GHR cells treated with IGF-I. Phosphatidylinositol 3-kinase was required for both survival and proliferative responses to IGF-I. Transfection of a dominant negative form of AKT (AH-AKT) resulted in suppression of IGF-I-mediated cell survival, but not of the antiapoptotic effect of GH in Ba/F3 GHR cells. Thus, GH and IGF-I are able to promote cell survival and proliferation through independent and different pathways in Ba/F3 cells.
引用
收藏
页码:2968 / 2977
页数:10
相关论文
共 36 条
[1]   Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase [J].
Ahmed, NN ;
Grimes, HL ;
Bellacosa, A ;
Chan, TO ;
Tsichlis, PN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3627-3632
[2]   Mechanism of activation of protein kinase B by insulin and IGF-1 [J].
Alessi, DR ;
Andjelkovic, M ;
Caudwell, B ;
Cron, P ;
Morrice, N ;
Cohen, P ;
Hemmings, BA .
EMBO JOURNAL, 1996, 15 (23) :6541-6551
[3]   Evidence for a role of NF-κB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor β fusion protein [J].
Besançon, F ;
Atfi, A ;
Gespach, C ;
Cayre, YE ;
Bourgeade, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8081-8086
[4]  
Blair LAC, 1999, J NEUROSCI, V19, P1940
[5]   Activation of growth hormone receptor delivers an antiapoptotic signal:: Evidence for a role of Akt in this pathway [J].
Costoya, JA ;
Finidori, J ;
Moutoussamy, S ;
Señaris, R ;
Devesa, J ;
Arce, VM .
ENDOCRINOLOGY, 1999, 140 (12) :5937-5943
[6]   Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling [J].
Craddock, BL ;
Orchiston, EA ;
Hinton, HJ ;
Welham, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (15) :10633-10640
[7]  
DATTA K, 1995, MOL CELL BIOL, V15, P2304
[8]  
DEL PL, 1997, SCIENCE, V278, P687
[9]  
DiDonato J, 1996, MOL CELL BIOL, V16, P1295
[10]   THE PROLINE-RICH REGION OF THE GH RECEPTOR IS ESSENTIAL FOR JAK2 PHOSPHORYLATION, ACTIVATION OF CELL-PROLIFERATION, AND GENE-TRANSCRIPTION [J].
DINERSTEIN, H ;
LAGO, F ;
GOUJON, L ;
FERRAG, F ;
EXPOSITO, N ;
FINIDORI, J ;
KELLY, PA ;
POSTELVINAY, MC .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (12) :1701-1707